Winway Health Desk
A First for Fatty Liver: FDA Approves Madrigal Pharma NASH Drug
A chronic metabolic disease in which fat buildup leads to worsening liver function that can ultimately require an organ transplant now has its first...
FDA Approves Tevimbra (tislelizumab-jsgr) for the Treatment of Advanced or Metastatic...
FDA Approves Tevimbra (tislelizumab-jsgr) for the Treatment of Advanced or Metastatic Esophageal Squamous Cell CarcinomaBASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS...
FDA Grants Accelerated Approval for Rezdiffra (resmetirom) for the Treatment of...
FDA Grants Accelerated Approval for Rezdiffra (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH)CONSHOHOCKEN, Pa., March 14, 2024...
HiLabs Secures $39M for AI-Powered Data Management Solutions
HiLabs, a company that uses AI to manage dirty data, has raised $39 million in Series B funding, the company announced Thursday.
Bethesda, Maryland-based HiLabs...
GE HealthCare & Mass General Brigham Have a Plan to Accelerate...
On Tuesday at the HIMSS conference in Orlando, GE HealthCare and Mass General Brigham announced that they are integrating foundation models into their AI...
AstraZeneca Acquisition Brings Drug to Fill a Rare Disease Gap Left...
AstraZeneca is bolstering its rare disease pipeline with a deal to buy Amolyt Pharma, a biotech company in late-stage development with a therapy designed...
GLP-1s Alone Are Not the Answer to America’s Obesity and Chronic...
The surge in demand for GLP-1-type weight loss medications has shone a bright light on the prevalence and persistence of obesity in American society...
Build My Health Webinar Highlights New Age for Physician Practices with...
The healthcare industry has embraced GLP1 drugs as an effective way to lose weight. But the popularity of these drugs has made them tough...
Ashtanga Hridayam Nidanasthanam Chapter 1: Sarvaroga Nidanam Adhyaya (Diagnosis of diseases...
The 1st chapter of Nidanasthanam of Ashtanga Hridayam is named as Sarvaroga Nidanam Adhyaya. This chapter deals with the explanation of ‘diagnosis of diseases...
Mirum Pharmaceuticals’ Livmarli Receives FDA Approval for Treatment of Cholestatic Pruritus...
FOSTER CITY, Calif.--(BUSINESS WIRE) March 13, 2024 -- Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that the U.S. Food and...